Purpose: The purpose of this study was to implement a machine learning model to predict skin dose from targeted intraoperative (TARGIT) treatment resulting in timely adoption of strategies to limit excessive skin dose. Methods: A total of 283 patients affected by invasive breast carcinoma underwent TARGIT with a prescribed dose of 6 Gy at 1 cm, after lumpectomy. Radiochromic films were used to measure the dose to the skin for each patient. Univariate statistical analysis was performed to identify correlation of physical and patient variables with measured dose. After feature selection of predictors of in vivo skin dose, machine learning models stepwise linear regression (SLR), support vector regression (SVR), ensemble with bagging or boosting, and feed forward neural networks were trained on results of in vivo dosimetry to derive models to predict skin dose. Models were evaluated by tenfold cross validation and ranked according to root mean square error (RMSE) and adjusted correlation coefficient of true vs predicted values (adj-R 2 ). Results: The predictors correlated with in vivo dosimetry were the distance of skin from source, depth-dose in water at depth of the applicator in the breast, use of a replacement source, and irradiation time. The best performing model was SVR, which scored RMSE and adj-R 2 , equal to 0.746 [95% confidence intervals (CI), 95% CI 0.737,0.756] and 0.481 (95% CI 0.468,0.494), respectively, on the tenfold cross validation. Conclusion: The model trained on results of in vivo dosimetry can be used to predict skin dose during setup of patient for TARGIT and this allows for timely adoption of strategies to prevent of excessive skin dose.
INTRODUCTION
An intraoperative radiotherapy (IORT) technique called TAR-GIT (targeted intraoperative radiotherapy) has been developed based on the Intrabeam system (Carl Zeiss, Oberkochen,
Germany). In this technique, a point source, emitting low energy x rays of 50 kVp coupled with a spherical applicator, is inserted into the surgical bed. The irradiation is administered soon after the primary tumor resection during the same operative session. The target tissue is the breast volume surrounding the excised tumor, wrapped around the radiotherapy source soon after the primary surgery. Two multicenter prospective randomized trials, Targit-A and Targit-B, are currently testing the clinical efficacy of TARGIT, as partial breast technique in selected early-stage low-risk breast cancer patients, and as a boost to the tumor bed before conventional whole breast irradiation (WBRT) for high risk patients, respectively. 1 The skin represents the main organ at risk in TARGIT, because of its proximity to the source. A few cases of dermatitis and skin necrosis have been reported in early reports 2, 3 as well as more recently 4 on this technique. No complications have been reported to other organs such as rib cage, lungs, and heart, receiving a lower dose of radiation because of their larger distance from the radiation source and steep dose fall-off. Safety levels for skin effects as low as 1 Gy 5 or 2 Gy 6 have been recommended to the skin after single fraction low kV irradiation. A dose of 6 Gy has been identified as a reasonably threshold for transient skin injury. One case of grade 2 dermatitis was reported after IORT delivered as a boost prior to WBRT where dose measured by in vivo dosimetry was 8.42 Gy. 7 As skin dose can be critical for IORT, many studies focused on developing techniques to measure in vivo dose to the skin using different types of dosimeter, including radiochromic films, 8 Thermoluminescent dosimeters (TLDs), 9, 10 and optically stimulated luminescent dosimeters (OSLDs).
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In vivo measurements of dose are also essential as they help identifying systematic and random errors in treatment delivery. 12, 13 Currently, individual pretreatment calculation of skin dose is challenged by the lack of treatment planning, mainly due to unsolved difficulties in installing useful in-room imaging systems, one of the major limitations of IORT techniques. 14 In the present study, we want to implement a model to estimate dose to the skin in TARGIT before beginning of the IORT treatment. This tool would allow timely adoption of strategies to prevent excessive skin dose, such as placing a saline solution-soaked gauze as a spacer around the applicator, in order to increase source to skin distance. For this purpose, we use statistical and/or machine learning algorithms able to infer a hypothesis (the function/model), to predict the labels (skin dose) of out-of-sample observations. 15, 16 With the goal of achieving the best possible accuracy, the models are trained on data from in vivo skin dosimetry performed with an established technique on a large cohort of patients during more than 4 yr of TARGIT practice at our center.
METHODS AND MATERIALS

2.A. Patient data and follow-up
From October 2013 to March 2018, 283 patients with invasive breast carcinoma underwent TARGIT after lumpectomy. Patients and treatments relevant data are summarized in Table I .
Patients were evaluated by expert breast surgeons during the 3 days after lumpectomy and then weekly until the complete wound healing. Incidences of acute toxicities, and in particular acute skin reactions, were collected during the first months after IORT. Subsequent clinical follow-up was scheduled every 6 months during the first 3 yr after IORT and then yearly. Bilateral mammography and ultrasonography were performed annually and late toxicities were evaluated during the follow-up visits.
2.B. In vivo dosimetry
During surgery, a wide local excision was carried out to remove the tumor. A spherical applicator with the proper size was chosen based on the excision cavity. A purse string suture was then applied deeply to the whole cavity edges. 17 The treatment delivery time was calculated by the Medical Physics staff using the Intrabeam Treatment Software, in order to deliver a prescribed dose of 5 or 6 Gy to 1 cm from the applicator surface in water, with 50 kVp, 40 lA x rays. The source was attached to the applicator and the gantry. Once the applicator was in place, the purse string was tightened carefully so that the breast tissue wrapped around the applicator. In order to prevent excessive irradiation of the skin, the edges were kept at least 1 cm away from the applicator shaft. 3 Gafchromic EBT3 (Ashland Special Ingredients, Bridgewater, NJ, USA) films were used to measure dose to the skin on patients who underwent TARGIT. Because the sensitive layer of the film is 0.125 mm from the surface of the patient, correction for the effective point of measurement is negligible for radiochromic films, 18 and it can be safely assumed that EBT3 measures directly the skin dose. Before the surgical procedure, pieces of radiochromic films were wrapped by a nurse of the surgical staff in a thin sterile envelope. Films were calibrated in air using the Intrabeam with spherical applicators, following a previously established procedure. 8 Two sheets of tungsten-impregnated rubber (0.1 mm lead equivalent; Carl Zeiss Surgical) were placed over the wound, thus covering also the films, to reduce the amount of stray radiation in the operating room during irradiation. Once the treatment finished, the purse string was cut, and the applicator and the shield were removed. 17 Films were collected and scanned using an Epson Expression 1680 (Epson-Seiko Corporation, Japan) flatbed scanner, and film images were converted into dose matrices according to a multichannel scanning protocol. [19] [20] [21] For measurement of dose and its uncertainty, average dose and standard deviation were calculated inside a region of interest (ROI) consisting of a 2 9 2 mm 2 square around the highest dose reading on the piece of film and positioned at least 2 mm from the film edges.
2.C. Statistical analysis
For each patient, age, laterality of breast cancer, and quadrant of breast (inner/midline/outer and upper/medial/lower) where the source was introduced were registered. Before placing the dosimeter, the point where the spherical applicator is at minimum depth under the patient skin was found by palpation. Then, the minimum depth, d min , of the spherical applicator was measured by insertion of a needle and measurement of the extent of needle insertion. The film was placed at the same position on the skin from which d min was measured [Supplementary Information Figs. S1(a)-S1(d)]. The distance from the point of measurement to the point of insertion of the source along the skin was also collected using a ruler. The value of depth-dose curve at d min , D(d min ) calculated by the Intrabeam software was also recorded, as it was previously postulated to be related to measured skin dose. 10, 22 The prescribed dose, diameter of the spherical applicator, and irradiation time were recorded among the variables related to treatment. Our Intrabeam system has two x-ray sources (serial numbers 321 and 338, respectively). When one of the two sources was not available because of maintenance, repair, or recalibrations, Zeiss provided a temporary replacement. It was also then recorded if source 1, 2 or a replacement source was used. Univariate statistical analysis was performed to find correlation of variables with measured dose, using the Spearman rank correlation test for ordinal variables, while the Kruskal-Wallis rank test was used for categorical variables.
2.D. Model implementation
Before training models, outliers were removed by performing a nonlinear multivariate regression using support vector machine (SVM), which was preferred because of its capability to deal with linear and nonlinear functional mappings. The data points whose residuals were three times higher than the standard deviation (larger than 99% confidence level) of the residuals of the entire dataset, were considered as possibly caused by incorrect measure of distance and/or depth, and were removed from analysis as outliers. Then, the least absolute shrinkage and selection operator (LASSO) 23 was applied in order to eliminate redundant variables that are likely not to be related to the measured dose.
First, an univariable linear regression was attempted using the most relevant predictor, D(d min ) with the aim to investigate if in vivo dosimetry can be predicted also using a unimetric model. Then, the following statistical and machine learning algorithms were trained on the dataset (predictors and in vivo dose from patients) to build multimetric models able to predict in vivo dose:
1. Stepwise linear regression (SLR), which results in a linear multimetric model; terms from a linear or generalized linear model are removed or added in order to find the subset of variables in the dataset resulting in the smallest model with lowest prediction error. 24 2. SVR is the regression version of SVM, a supervised machine learning technique which, by means of a kernel function, projects the data into a higher dimensional feature space and can perform linear regression in this high-dimensional feature space. SVR tolerates errors that are inferior to a margin, thus providing a trade-off between goodness of fit and model robustness. 25 3. Ensemble machine learning (EML) uses multiple learners aggregated into a single learner. We used for weak learners Decision Trees, a popular concept in machine learning. 15 In EML with bagging (EML/ bag), a group of decision trees is trained, and the algorithm randomizes training samples by resampling with replacements; second, at each branching step, it chooses an attribute to split among a randomly selected subset of attributes. After a bag of trees is trained, prediction is made for all the individual trees and the most frequent class selected by the trees is taken as a final result. 26 4. EML with boosting (EML/boost), where decision trees are trained sequentially on subsets containing the data that were misclassified in previous training steps, then they are feedback in order to boost performance. 27 5. Feed-forward neural network (NN) using Bayesian regularization training algorithm. Neural networks are described as parallel-distributed computational models that consist of many nonlinear elements arranged in patterns that imitate biological nervous systems. In order to compare the performance of the different models, we used the root mean square error (RMSE) which describes the difference among modeled and measured dose, and the adjusted correlation coefficient (adj-R 2 ) of predicted and measured data, which reflects the goodness of fit of the model to the population taking into account the sample size and the number of predictors used. 29 
2.E. Cross validation and analysis of sample size
In order to test out-of-sample accuracy, tenfold cross validation, where the 267 patients were randomly partitioned into ten subsamples of nearly equal size, was performed. Nine subsamples were used to train the model, which was validated on the tenth subsample. Then, the training and validation subsamples were rotated, so that all patients are used once in the validation subsample. RMSE and adj-R 2 were calculated from results in the validation subsamples (RMSE v and adj-R 2 v ). The whole process was repeated 100 times in order to derive average values and 95% confidence intervals (95% CI) of RMSE v and adj-R In order to determine if the dataset was large enough to build a multivariable model, the SVR was performed on randomly chosen samples of increasing number of patients. The procedure was repeated 1000 times for each sample size. The P-value of a t-test (zero vs nonzero coefficient in the SVR) was performed for the three most predictive variables: D (d min ), distance, and use of a replacement source. The sample size was considered large enough to build a multivariable model when all these three variables reached a P-value under the 0.05 significance level.
RESULTS
3.A. Patients results
The mean measured skin dose was 3.21 Gy, (95% CI 1.53-5.38 Gy). No acute radiation injury to the skin, necrosis, skin breakdown or delayed wound healing was observed during the patients' follow-up. None of the patients showed evidence of significant clinical complications. No late toxicity (i.e., hyperpigmentation, telangiectasia, ulceration) was found. In patients who received WBRT after TARGIT, no additional risk of skin toxicity was detected in the skin area close to the lumpectomy.
3.B. Statistical analysis
The results of the univariate statistical analysis are shown in Table II . The in vivo measured dose was strongly (P < 0.0001) correlated with D(d min ), distance of film from the applicator, and applicator diameter. Significant but weaker correlations (P < 0.05) were found with prescribed dose, irradiation time, and Intrabeam source used. In vivo dose was uncorrelated with tumor laterality, point of insertion of the source, and patient age.
3.C. Models development
A total of 16 measurements (5.6%) were removed from the analysis as outliers. In the feature selection, the following variables were selected, and then passed to the machine learning algorithms: prescribed dose, D(d min ), use of a replacement source, applicator diameter, laterality of breast (left and right), outer and superior position of the source, distance of the film, and d min .
The plots of estimated vs measured dose from calibration and validation of machine learning methods are shown in Fig. 1 . The performances in training and tenfold cross validation are compared in Table III , and the distributions of RMSE v and adj-R (Fig. 3) shows that the P-values for inclusion of the three most predictive variables in the SVR model were all below 0.05 for sample size larger than 91 patients. Therefore, the dataset of 267 patients used in the analysis was considered largely adequate to build multivariable models predictive of in vivo dose.
DISCUSSION
Studies reported results of in vivo dosimetry in patients who received TARGIT as soon as the skin was recognized as the main organ at risk during this procedure. In vivo dosimetry in a series of 72 patients resulted in average measured dose of 2.9 Gy, with 11% of readings ≥6 Gy. 10 Measurements with TLD on the skin at distances of 5 and 15 mm from the incision on 57 patients resulted in maximum dose of 2.93 Gy on average. 9 The distribution of skin doses measured in our patient dataset is in agreement with the previous studies.
It is no surprise that, in our results, the variable with the strongest correlation was D(d min ) in water, as it describes the dependency of dose from the applicator diameter, depth of the applicator, the prescribed dose, and the amount of tissue between the skin and the applicator. However, the linear regression model based on D(d min ) resulted in poor predictive capability compared to other models, thus showing the advantage of using multimetric machine learning to predict skin dose.
The univariate statistical analysis confirmed the dependencies of in vivo measured skin dose on distance from the measured point from the applicator shaft, in agreement with previous reports. 9, 10 The distance from the applicator shaft was an independent predictor of skin dose possibly because, for a fixed depth, an increase in distance implies a different geometry of irradiation, where the applicator is more oblique. Monte Carlo simulation of a breast phantom with realistic tissue compositions and skin layers, demonstrated that in vivo dose depends on the size of applicator 22 as well as the amount of breast tissue between the applicator and the skin. In the study of Fogg et al., 9 the ratios between average doses measured with TLDs at 5 mm and at 15 mm from the point of insertion were 1.47, 1.22, 1.24, and 1.11 for the 3.5, 4.0, 4.5, and 5.0 cm applicators, respectively. This effect has been explained with more penetrating beam spectrum with larger applicators, 22 but it should also be noted that the use of larger applicators is preferred on patients with larger breast size, as confirmed by correlation in our dataset among d min and applicator diameter (Spearman correlation test P ( 0.0001).As expected, in the univariate analysis, measured dose was also correlated with other variables related to the quantity of radiation emitted, such as the irradiation time and the prescribed dose which is specified, according to the TARGIT protocol, as the dose at 1 cm from the applicator surface in water. Seven units were used for spare sources, when one of the two sources was not available because of maintenance, repair or recalibrations, and the use of a replacement source was related to in vivo dose. Dosimetric and spectrum characteristics different from the other sources may explain this result. Differences in the output dose rate of different sources have been reported. 30 However, given that the dose rate is checked and, if necessary, readjusted before each treatment, 4 these are unlikely to affect measured dose. Small differences in the various structures involved in the generation of x rays, including the electron source, the beam deflector as well as the gold target, such as between manufactured and ideal target thickness, could change photon spectra and doses between different sources, thus explaining a change of dose. 22 In our results, the feature selection successfully removed those variables that are not correlated with measured dose (e.g., age) and those that suffer from collinearity and are redundant, such as d min , which is related to D(d min ).
Among the multimetric machine learning models, SVR showed the best performance (lowest RMSE and highest adj-R 2 ) on the cross validation, and therefore, we consider it as the model of choice. This result is in agreement with other reports where SVM classifiers were among the best performing machine learning methods. 31 The second best method, SLR, has the advantage to provide a simple calculation to be used in an operating room. For this reason, the formula resulting from the SLR is shown in Table IV .
Our machine learning models were trained on a dataset of 283 patients, which is the largest published results of in vivo dosimetry in IORT. The plot of the model residuals shows that the in vivo dose calculated by considered models has uncertainties. A possible explanation for the residuals could be the manual measurements of d min and distance, whose accuracy could be improved, for example, by using ultrasound imaging to measure the thickness of breast tissue between the applicator and the point of interest. Skin dose may also vary because of variation in the compositions of the treated breast. Treatments are usually performed covering the patient surface over the applicator with a lead-rubber protection sheet whose backscatter could increase skin dose, however, to a relatively small amount.
14 As all our treatments were performed with the protection sheet, it was not possible to verify how much the skin dose is dependent on its use. By using the model recommended by this study, it is possible to anticipate measured in vivo dose from TARGIT in the operating room. This work shows that the machine learning approach can be applied to in vivo dosimetry, as successfully done in other areas of radiotherapy workflow, including error detection and prevention, 16 treatment dose planning, 32 and verification. 33, 34 It also suggests that the results of in vivo dosimetry should be included among other categories of patient data in the electronic patient records in order to be available for automated data extraction with the aim of generating or improving prediction models for patient dose.
A word of caution is needed. The availability of the models provided here to predict skin dose should not prevent measured in vivo dosimetry to the skin, which remains fundamental as an independent quality check of radiotherapy identifying errors in delivery, for example, caused by wrong calibration of the machine. In vivo dosimetry still holds as an effective method to validate the introduction and any modification to the delivery of this intraoperative technique by measuring dose to the skin and other critical structures as required.
CONCLUSION
This work shows the potential of extending the machine learning approach to in vivo dosimetry in IORT. Models for the prediction of in vivo dose to the skin in TARGIT were derived from measurements of skin dose performed for over 4 yr at our center with a consistent technique. Of the machine learning models used, SVR was the best performing model and can be used to predict and evaluate dose to the skin before treatment delivery and to adopt measures to minimize excessive dose to the skin.
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